Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

Por C. Bazzani, M. Frassi, P. Airò, S. Zingarelli, M. Scarsi, M. Puoti
Publicado em 2011-09-01

Long-term effects of cyclic therapy with iloprost in systemic sclerosis

Por A. Grottolo, A. Frigè, E. Danieli, M. Rossi, M. Scarsi, A. Zambruni, P. Airò
Publicado em 2011-09-01

Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

Por P. Airò, R. Gorla, M. Vianelli, M. Frassi, E. Danieli, F. Franceschini, I. Cavazzana, R. Cattaneo
Publicado em 2011-09-01

Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center

Por F. Dall'Ara, I. Cavazzana, M. Frassi, M. Taraborelli, M. Fredi, F. Franceschini, L. Andreoli, M. Rossi, C. Cattaneo, A. Tincani, P. Airò
Publicado em 2018-07-01

3.5 EFFECT OF SHORT-TERM TREATMENT WITH LERCANIDIPINE ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND STRUCTURAL ALTERATIONS IN RETINAL ARTERIOLES

Por C. De Ciuceis, C. Rossini, E. La Boria, S. Duse, F. Semeraro, C. Agabiti Rosei, P. Airò, M. Scarsi, A. Tincani, M.L. Muiesan, A. Paini, M. Salvetti, E. Porteri, E. Agabiti Rosei, D. Rizzoni
Publicado em 2012-11-01